Search results
Results from the WOW.Com Content Network
Piperacillin with tazobactam is administered through an intravenous (IV) method, where it is infused into the bloodstream over a period of 30 minutes to 4 hours so that the medication is delivered slowly and steadily.
The studies supporting this theory generally administered ~3.375 g of piperacillin-tazobactam every 8 hours during a 4-hour infusion, while for organisms with higher minimum inhibitory concentrations, ~4.5 g of piperacillin-tazobactam was administered every 6 hours during a 3-hour infusion. [20]
C 10 H 12 N 4 O 5 S: Molar mass: 300.29 g·mol ... Tazobactam is combined with the extended spectrum β-lactam antibiotic piperacillin in the drug piperacillin ...
The β-lactam core structures. (A) A penam.(B) A carbapenam.(C) An oxapenam.(D) A penem.(E) A carbapenem.(F) A monobactam.(G) A cephem.(H) A carbacephem.(I) An oxacephem. This is a list of common β-lactam antibiotics—both administered drugs and those not in clinical use—organized by structural class.
occasionally penicillins including penicillin, ampicillin and ampicillin-sulbactam, amoxicillin and amoxicillin-clavulnate, and piperacillin-tazobactam (not all vancomycin-resistant Enterococcus isolates are resistant to penicillin and ampicillin) occasionally doxycycline and minocycline
Azlocillin Piperacillin Mezlocillin. The ureidopenicillins are a group of penicillins which are active against Pseudomonas aeruginosa. [citation needed] There are three ureidopenicillins in clinical use: [1] Azlocillin; Piperacillin; Mezlocillin
ATC code J01 Antibacterials for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
Tazobactam, usually combined with piperacillin (Zosyn, Tazocin) Enmetazobactam, usually combined with cefepime ; β-lactamase inhibitors with a diazabicyclooctane core: Avibactam, approved in combination with ceftazidime (Avycaz, Zavicefta), currently undergoing clinical trials for combination with ceftaroline